Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Toner

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selectionG C Toner, D M Panicek, R T Heelan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Phase I trial of cremophor EL with bolus doxorubicinM J Millward, L K Webster, D Rischin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparisonG C Toner, J D Shapiro, C R Laidlaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancerJ F Bishop, J Dewar, G C Toner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 2013
Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapyI N Olver, P Grimison, M Chatfield, et al.
Cytotherapy|May 15, 2002
CliniMACS CD34-selected cells to support multiple cycles of high-dose therapyH M Prince, D Wall, D Rischin, et al.
Lancet (London, England)|March 20, 2001
Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial GroupG C Toner, M R Stockler, M J Boyer, et al.
Internal Medicine Journal|August 2, 2014
Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort studyB O'Carrigan, M Fournier, I N Olver, et al.
Bone Marrow Transplantation|December 2, 2000
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, D Rischin, G C Toner, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selectionG C Toner, D M Panicek, R T Heelan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Phase I trial of cremophor EL with bolus doxorubicinM J Millward, L K Webster, D Rischin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparisonG C Toner, J D Shapiro, C R Laidlaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancerJ F Bishop, J Dewar, G C Toner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 2013
Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapyI N Olver, P Grimison, M Chatfield, et al.
Cytotherapy|May 15, 2002
CliniMACS CD34-selected cells to support multiple cycles of high-dose therapyH M Prince, D Wall, D Rischin, et al.
Lancet (London, England)|March 20, 2001
Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial GroupG C Toner, M R Stockler, M J Boyer, et al.
Internal Medicine Journal|August 2, 2014
Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort studyB O'Carrigan, M Fournier, I N Olver, et al.
Bone Marrow Transplantation|December 2, 2000
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I studyH M Prince, D Rischin, G C Toner, et al.
Pageof 6